Clinical Trials Sponsored by Genpharm ULC

Total 12307 results

Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State

Healthy

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State

Healthy

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects

Therapeutic Equivalency

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects

Therapeutic Equivalency

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State

Healthy

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Clarithromycin 250 mg Tablets

Healthy

Canada
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients

Clamp Study

Russian Federation
Geropharm

Completed

Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients

Diabetes Mellitus | Diabetes Mellitus, Type 1

Russian Federation
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro to Humalog® in Healthy Subjects

Clamp Study

Russian Federation
Geropharm

Completed

Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions

Bioequivalence

Russian Federation
Geropharm

Completed

Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

Bioequivalence

Russian Federation
Geropharm

Completed

Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia)

Bioequivalence

Russian Federation
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects

Clamp Study

Russian Federation
Geropharm

Completed

Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus

Russian Federation
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mix 25 to Humalog® Mix 25 in Healthy Subjects

Clamp Study

Russian Federation
Geropharm

Completed

Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects

Bioequivalence

Russian Federation
Geropharm

Recruiting

Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141

Pharmacokinetics | Pharmacodynamics | Bioequivalence

Russian Federation
Geropharm

Completed

Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method

Bioequivalence | Therapeutic Equivalency

Russian Federation
Geropharm

Completed

Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) in Healthy Volunteers and Outpatients With COVID-19

Pharmacokinetics | Efficacy | Safety Issues

Russian Federation
Geropharm

Completed

Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

Pharmacokinetics | Bioequivalence

Russian Federation
Geropharm

Completed

Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients

Diabetes | Diabetes Mellitus, Type 1

Russian Federation
Geropharm

Unknown

Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus

Russian Federation
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects

Clamp Study

Russian Federation
Geropharm

Completed

Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects

Bioequivalence

Russian Federation
Geropharm

Completed

Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2

Russian Federation
Geropharm

Completed

Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects

Bioequivalence, AUC, Cmax, Pharmacokinetics

Russian Federation
KemPharm, Inc.

Completed

KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD

ADHD

United States
KemPharm, Inc.

Completed

KP415 Classroom Study in Children (6-12 Years of Age) With ADHD

ADHD

United States
Neopharm Bulgaria Ltd.

Recruiting

Treatment of Adults With Acute Bronchitis in the Primary Healthcare Setting (AАBA)

Acute Bronchitis

Bulgaria
Neopharm Bulgaria Ltd.

Completed

Efficacy and Safety of Sinquanon for Prevention of Antibiotic-associated Diarrhea in Adults (SPAADA)

Antibiotic-associated Diarrhea

Bulgaria
KemPharm Denmark A/S

Completed

A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C

Niemann-Pick Disease, Type C

Spain, France, United Kingdom, Switzerland, Denmark, Poland, Italy, Germany
KemPharm Denmark A/S

Terminated

Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3

Gaucher Disease, Type 1 | Gaucher Disease, Type 3

India
Universidad de Valparaiso
Recalcine (GynoPharm)

Completed

Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women

Overactive Bladder

Chile
Abbott
Jenapharm GmbH & Co. KG

Completed

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.

Endometriosis
EnhancedBio USA Inc.
Zenopharm

Recruiting

ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study) (ENZENO)

Metastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-Positive

United States, Korea, Republic of
Melanie Hayden Gephart
Quadriga Biosciences, Inc.

Recruiting

Study Assessing QBS72S For Treating Brain Metastases

Breast Cancer | Brain Metastases

United States
UMC Utrecht
MedImmune LLC

Completed

Advanced Understanding of Staphylococcus Aureus Infections in Europe - Surgical Site Infections (ASPIRE-SSI)

Staphylococcus Aureus | Surgical Wound Infection

United Kingdom, Netherlands, Spain, Czechia, Serbia, Belgium, France, Estonia, Italy, Romania
Pontificia Universidad Catolica de Chile
University of Chile; Laboratorio Gynopharm - CFR

Unknown

A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders

Premature Birth | Fetal Growth Retardation | Preeclampsia | Stillbirth

Chile
Angle plc
MidLantic Urology, LLC

Terminated

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System (CHARTER)

Prostate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate Carcinoma

United States
Synochi, LLC
LAC+USC Medical Center

Not yet recruiting

Prospective Placebo-controlled Study of Synochi Scar Spray

Burns Multiple
UMC Utrecht
Merck Sharp & Dohme LLC

Unknown

RAltegravir Switch STudy: Effects on Endothelial Recovery (RASSTER)

HIV Infection | Endothelial Dysfunction

Netherlands
MedRegen LLC
Johns Hopkins University; ICON plc

Recruiting

MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

COVID-19 | ARDS, Human | Regeneration | Stem Cells

United States
Verily Life Sciences LLC
The Emmes Company, LLC; Optos, PLC; Google LLC.; Nikon Corporation

Completed

ARDA Software for the Detection of mtmDR

Diabetic Retinopathy

United States
Redx Pharma Plc
Merck Sharp & Dohme LLC

Completed

A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) (KEYNOTE-E86)

Advanced Solid Tumours

United Kingdom, Australia
4D pharma plc
Merck Sharp & Dohme LLC

Terminated

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Melanoma | Renal Cell Carcinoma | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Oncology

United States
UMC Utrecht
Ferring Pharmaceuticals; Merck Sharp & Dohme LLC

Completed

Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Prospective Cohort Study

Colorectal Cancer | Inflammatory Bowel Disease

Netherlands
Jan Kluytmans
MedImmune LLC; Universiteit Antwerpen

Completed

Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU (ASPIRE-ICU)

Pneumonia | Nosocomial Pneumonia | Pneumonia, Ventilator-Associated

Netherlands
Amsterdam UMC, location VUmc
Merck Sharp & Dohme LLC

Unknown

89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer

Non Small Cell Lung Cancer

Netherlands
UNC Lineberger Comprehensive Cancer Center
Merck Sharp & Dohme LLC

Completed

Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker

Melanoma

United States
UNC Lineberger Comprehensive Cancer Center
Merck Sharp & Dohme LLC

Completed

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

Non Small Cell Lung Cancer

United States

3

Subscribe